Development of a transgenic mouse with R124H human TGFBI mutation associated with granular corneal dystrophy type 2

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Yamazoe, Katsuya ^a   Yoshida, Satoru ^a   Yasuda, Miyuki ^a   Hatou, Shin ^a   Inagaki, Emi ^a   Ogawa, Yoko ^a   Tsubota, Kazuo ^a   Shimmura, Shigeto ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; TRANSFORMING GROWTH FACTOR BETA; LIGHT CHAIN 3, HUMAN; MAP1LC3 PROTEIN, MOUSE; MICROTUBULE ASSOCIATED PROTEIN; PRIMER DNA; TGFB1 PROTEIN, HUMAN; THIAZOLE DERIVATIVE; THIOFLAVINE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; CORNEA DYSTROPHY; CORNEA OPACITY; CROSS-SECTIONAL STUDY; ELECTRON MICROSCOPY; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GRANULAR CORNEAL DYSTROPHY TYPE 2; HETEROZYGOTE; HISTOPATHOLOGY; HOMOZYGOTE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INCIDENCE; MOUSE; MOUSE MODEL; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TGFBI GENE; TRANSGENIC MOUSE; WILD TYPE MOUSE; ALLELE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CHEMISTRY; CONGENITAL CORNEA DYSTROPHY; DISEASE MODEL; FEMALE; GENETICS; GENOTYPE; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; METABOLISM; MUTATION; NUCLEOTIDE SEQUENCE;

ALLELES; ANIMALS; BASE SEQUENCE; CORNEAL DYSTROPHIES, HEREDITARY; DISEASE MODELS, ANIMAL; DNA PRIMERS; DNA, COMPLEMENTARY; FEMALE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, TRANSGENIC; MICROSCOPY, ELECTRON; MICROTUBULE-ASSOCIATED PROTEINS; MUTATION; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THIAZOLES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84941241973     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0133397     Document Type: Article

References (26)

1. Folberg R, Alfonso E, Croxatto JO, Driezen NG, Panjwani N, Laibson PR, et al. Clinically atypical granular corneal dystrophy with pathologic features of lattice-like amyloid deposits. A study of these families. Ophthalmology. 1988; 95(1):46-51. Epub 1988/01/01. PMID: 3278259.
2. Fujiki K, Nakayasu K, Kanai A. Corneal dystrophies in Japan. J Hum Genet. 2001; 46(8):431-5. Epub 2001/08/15. doi:10.1007/s100380170041 PMID: 11501939.
3. Mashima Y, Yamamoto S, Inoue Y, Yamada M, Konishi M, Watanabe H, et al. Association of autosomal dominantly inherited corneal dystrophies with BIGH3 gene mutations in Japan. Am J Ophthalmol. 2000; 130(4):516-7. Epub 2000/10/12. PMID: 11024425.
4. Yamamoto S, Okada M, Tsujikawa M, Morimura H, Maeda N, Watanabe H, et al. The spectrum of beta ig-h3 gene mutations in Japanese patients with corneal dystrophy. Cornea. 2000; 19(3 Suppl):S21-3. Epub 2000/06/01. PMID: 10832717.
5. Mashima Y, Konishi M, Nakamura Y, Imamura Y, Yamada M, Ogata T, et al. Severe form of juvenile corneal stromal dystrophy with homozygous R124H mutation in the keratoepithelin gene in five Japanese patients. Br J Ophthalmol. 1998; 82(11):1280-4. Epub 1999/01/30. PMID: 9924333; PubMed Central PMCID: PMC1722402.
6. Okada M, Yamamoto S, Inoue Y, Watanabe H, Maeda N, Shimomura Y, et al. Severe corneal dystrophy phenotype caused by homozygous R124H keratoepithelin mutations. Invest Ophthalmol Vis Sci. 1998; 39(10):1947-53. Epub 1998/09/04. PMID: 9727418.
7. Konishi M, Yamada M, Nakamura Y, Mashima Y. Varied appearance of cornea of patients with corneal dystrophy associated with R124H mutation in the BIGH3 gene. Cornea. 1999; 18(4):424-9. Epub 1999/07/28. PMID: 10422854.
8. Abazi Z, Magarasevic L, Grubisa I, Risovic D. Individual phenotypic variances in a family with Avellino corneal dystrophy. BMC Ophthalmol. 2013; 13:30. Epub 2013/07/11. doi:10.1186/1471-2415-13-30 PMID: 23837658; PubMed Central PMCID: PMC3708762.
9. Han KE, Choi SI, Chung WS, Jung SH, Katsanis N, Kim TI, et al. Extremely varied phenotypes in granular corneal dystrophy type 2 heterozygotes. Molecular vision. 2012; 18:1755-62. Epub 2012/07/21. PMID: 22815629; PubMed Central PMCID: PMC3398492.
10. Choi SI, Kim TI, Kim KS, Kim BY, Ahn SY, Cho HJ, et al. Decreased catalase expression and increased susceptibility to oxidative stress in primary cultured corneal fibroblasts from patients with granular corneal dystrophy type II. Am J Pathol. 2009; 175(1):248-61. Epub 2009/06/06. doi:10.2353/ajpath.2009.081001 PMID: 19497990; PubMed Central PMCID: PMC2708811.
11. Choi SI, Dadakhujaev S, Ryu H, Im Kim T, Kim EK. Melatonin protects against oxidative stress in granular corneal dystrophy type 2 corneal fibroblasts by mechanisms that involve membrane melatonin receptors. J Pineal Res. 2011; 51(1):94-103. Epub 2011/03/12. doi:10.1111/j.1600-079X.2011.00866.x PMID: 21392093.
12. Choi SI, Kim BY, Dadakhujaev S, Oh JY, Kim TI, Kim JY, et al. Impaired autophagy and delayed autophagic clearance of transforming growth factor beta-induced protein (TGFBI) in granular corneal dystrophy type 2. Autophagy. 2012; 8(12):1782-97. Epub 2012/09/22. doi:10.4161/auto.22067 PMID: 22995918; PubMed Central PMCID: PMC3541288.
13. Kim TI, Kim H, Lee DJ, Choi SI, Kang SW, Kim EK. Altered mitochondrial function in type 2 granular corneal dystrophy. Am J Pathol. 2011; 179(2):684-92. Epub 2011/06/28. doi:10.1016/j.ajpath.2011.04.005 PMID: 21699880; PubMed Central PMCID: PMC3157179.
14. Choi SI, Kim BY, Dadakhujaev S, Jester JV, Ryu H, Kim TI, et al. Inhibition of TGFBIp expression by lithium: Implications for TGFBI-linked corneal dystrophy therapy. Invest Ophthalmol Vis Sci. 2011; 52 (6):3293-300. Epub 2011/02/12. doi:10.1167/iovs.10-6405PMID: 21310903.
15. Zhang Y, Wen G, Shao G, Wang C, Lin C, Fang H, et al. TGFBI deficiency predisposes mice to spontaneous tumor development. Cancer research. 2009; 69(1):37-44. Epub 2009/01/02. doi:10.1158/0008-5472.can-08-1648 PMID: 19117985; PubMed Central PMCID: PMC2664305.
16. de Sousa L, Mannis M. The Stromal Dystrophies. In: Krachmer J, Mannis M, Holland E, editors. Cornea. 3rd ed. St. Louis, MO: Mosby; 2011. p. 826-7.
17. Holland EJ, Daya SM, Stone EM, Folberg R, Dobler AA, Cameron JD, et al. Avellino corneal dystrophy. Clinical manifestations and natural history. Ophthalmology. 1992; 99(10):1564-8. Epub 1992/10/01. PMID: 1454323.
18. Cao W, Ge H, Cui X, Zhang L, Bai J, Fu S, et al. Reduced penetrance in familial Avellino corneal dystrophy associated with TGFBI mutations. Molecular vision. 2009; 15:70-5. Epub 2009/01/16. PMID: 19145249; PubMed Central PMCID: PMC2622714.
19. Awwad ST, Di Pascuale MA, Hogan RN, Forstot SL, McCulley JP, Cavanagh HD. Avellino corneal dystrophy worsening after laser in situ keratomileusis: Further clinicopathologic observations and proposed pathogenesis. Am J Ophthalmol. 2008; 145(4):656-61. Epub 2008/02/05. doi10.1016/j.ajo.2007.12.008 PMID: 18243154; PubMed Central PMCID: PMC2661203.
20. Jun RM, Tchah H, Kim TI, Stulting RD, Jung SE, Seo KY, et al. Avellino corneal dystrophy after LASIK. Ophthalmology. 2004; 111(3):463-8. Epub 2004/03/17. doi:10.1016/j.ophtha.2003.06.026 PMID: 15019320.
21. Wan XH, Lee HC, Stulting RD, Kim T, Jung SE, Kim MJ, et al. Exacerbation of Avellino corneal dystrophy after laser in situ keratomileusis. Cornea. 2002; 21(2):223-6. Epub 2002/02/28. PMID: 11862101.
22. Karring H, Runager K, Thogersen IB, Klintworth GK, Hojrup P, Enghild JJ. Composition and proteolytic processing of corneal deposits associated with mutations in the TGFBI gene. Exp Eye Res. 2012; 96 (1):163-70. Epub 2011/12/14. doi:10.1016/j.exer.2011.11.014 PMID: 22155582; PubMed Central PMCID: PMC3311163.
23. Basaiawmoit RV, Oliveira CL, Runager K, Sorensen CS, Behrens MA, Jonsson BH, et al. SAXS models of TGFBIp reveal a trimeric structure and show that the overall shape is not affected by the Arg124His mutation. J Mol Biol. 2011; 408(3):503-13. Epub 2011/03/05. doi:10.1016/j.jmb.2011.02.052PMID: 21371477.
24. Korvatska E, Henry H, Mashima Y, Yamada M, Bachmann C, Munier FL, et al. Amyloid and non-amyloid forms of 5q31-linked corneal dystrophy resulting from kerato-epithelin mutations at Arg-124 are associated with abnormal turnover of the protein. The Journal of biological chemistry. 2000; 275 (15):11465-9. Epub 2001/02/07. PMID: 10753964.
25. Grothe HL, Little MR, Sjogren PP, Chang AA, Nelson EF, Yuan C. Altered protein conformation and lower stability of the dystrophic transforming growth factor beta-induced protein mutants. Molecular vision. 2013; 19:593-603. Epub 2013/04/06. PMID: 23559853; PubMed Central PMCID: PMC3611947.
26. Kato Y, Yagi H, Kaji Y, Oshika T, Goto Y. Benzalkonium chloride accelerates the formation of the amyloid fibrils of corneal dystrophy-associated peptides. The Journal of biological chemistry. 2013; 288 (35):25109-18. Epub 2013/07/19. doi:10.1074/jbc.M113.477695 PMID: 23861389; PubMed Central PMCID: PMC3757175.